U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
VOPRATELIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(INDUCIBLE T-CELL COSTIMULATOR)(HUMANIZED MONOCLONAL JTX-2011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL JTX-2011 .KAPPA.-CHAIN, DIMER
Preferred Name English
VOPRATELIMAB [USAN]
Common Name English
vopratelimab [INN]
Common Name English
Vopratelimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-( HOMO SAPIENS INDUCIBLE T-CELL COSTIMULATOR (ANTIGEN CD278))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED VH (HOMO SAPIENS IGHV3-74*01 (89%) (IGHD)-IGHJ5*01) (8.8.10) (1-117)-HOMO SAPIENS IGHG1*03 (CH
Systematic Name English
JTX-2011
Code English
ANTI-ICOS AGONIST MAB JTX-2011
Common Name English
ANTI-ICOS AGONIST MONOCLONAL ANTIBODY JTX-2011
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C141145
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
Code System Code Type Description
USAN
FG-61
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
FDA UNII
QXN20J93AH
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
NCI_THESAURUS
C129876
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
INN
10730
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
DRUG BANK
DB15378
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
CAS
2039148-04-2
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
SMS_ID
100000181742
Created by admin on Tue Apr 01 22:01:55 GMT 2025 , Edited by admin on Tue Apr 01 22:01:55 GMT 2025
PRIMARY
ACTIVE MOIETY
VOPRATELIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966